APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Bioprocess Platform Software

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Bioprocess Platform Software Market Analysis and Forecast 2026-2032

Report ID 17407957021 January 2026190 pages

Choose your research edition.

Industry ResearchBioprocess Platform Software Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Bioprocess Platform Software Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Bioprocess Platform Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bioprocess Platform Software Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Bioprocess Platform Software Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Bioprocess Platform Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Bioprocess Platform Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Bioprocess Platform Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Bioprocess Platform Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Bioprocess Platform Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Bioprocess Platform Software include Eppendorf, BioReact, Infors AG, Thermo Fisher Scientific, Invert, Genedata, Novasign, Qubicon and BioRaptor, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Bioprocess Platform Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Bioprocess Platform Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Bioprocess Platform Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bioprocess Platform Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Bioprocess Platform Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Bioprocess Platform Software revenue, projected growth trends, production technology, application and end-user industry.

Bioprocess Platform Software Segment by Company

Eppendorf

BioReact

Infors AG

Thermo Fisher Scientific

Invert

Genedata

Novasign

Qubicon

BioRaptor

Merck

Bionet

Securecell

Vimachem

Scientific Industries

Bioprocess Platform Software Segment by Type

Cloud-based

On-premise

Bioprocess Platform Software Segment by Application

Upstream Processing (Cell Culture/Fermentation)

Downstream Processing (Purification)

Bioprocess Platform Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioprocess Platform Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bioprocess Platform Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioprocess Platform Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Bioprocess Platform Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Bioprocess Platform Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bioprocess Platform Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Bioprocess Platform Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cloud-based Major Player Table 3. On-premise Major Player Table 4. Global Bioprocess Platform Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Upstream Processing (Cell Culture/Fermentation) Major Player Table 6. Downstream Processing (Purification) Major Player Table 7. Bioprocess Platform Software Industry Trends Table 8. Bioprocess Platform Software Industry Drivers Table 9. Bioprocess Platform Software Industry Opportunities and Challenges Table 10. Bioprocess Platform Software Industry Restraints Table 11. Global Bioprocess Platform Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Bioprocess Platform Software Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Bioprocess Platform Software Market Share by Region (2021-2026) Table 14. Global Bioprocess Platform Software Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Bioprocess Platform Software Market Share by Region (2027-2032) Table 16. Global Bioprocess Platform Software Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Bioprocess Platform Software Revenue Market Share by Players (2021-2026) Table 18. Global Bioprocess Platform Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Bioprocess Platform Software Key Players Headquarters & Area Served Table 20. Global Bioprocess Platform Software Players, Product Type & Application Table 21. Global Bioprocess Platform Software Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Bioprocess Platform Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Bioprocess Platform Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Bioprocess Platform Software Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Bioprocess Platform Software Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Bioprocess Platform Software Revenue Market Share by Type (2021-2026) Table 28. Global Bioprocess Platform Software Revenue Market Share by Type (2027-2032) Table 29. Global Bioprocess Platform Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Bioprocess Platform Software Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Bioprocess Platform Software Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Bioprocess Platform Software Revenue Market Share by Application (2021-2026) Table 33. Global Bioprocess Platform Software Revenue Market Share by Application (2027-2032) Table 34. Eppendorf Company Information Table 35. Eppendorf Business Overview Table 36. Eppendorf Bioprocess Platform Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Eppendorf Bioprocess Platform Software Product Portfolio Table 38. Eppendorf Recent Development Table 39. BioReact Company Information Table 40. BioReact Business Overview Table 41. BioReact Bioprocess Platform Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. BioReact Bioprocess Platform Software Product Portfolio Table 43. BioReact Recent Development Table 44. Infors AG Company Information Table 45. Infors AG Business Overview Table 46. Infors AG Bioprocess Platform Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Infors AG Bioprocess Platform Software Product Portfolio Table 48. Infors AG Recent Development Table 49. Thermo Fisher Scientific Company Information Table 50. Thermo Fisher Scientific Business Overview Table 51. Thermo Fisher Scientific Bioprocess Platform Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Thermo Fisher Scientific Bioprocess Platform Software Product Portfolio Table 53. Thermo Fisher Scientific Recent Development Table 54. Invert Company Information Table 55. Invert Business Overview Table 56. Invert Bioprocess Platform Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Invert Bioprocess Platform Software Product Portfolio Table 58. Invert Recent Development Table 59. Genedata Company Information Table 60. Genedata Business Overview Table 61. Genedata Bioprocess Platform Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Genedata Bioprocess Platform Software Product Portfolio Table 63. Genedata Recent Development Table 64. Novasign Company Information Table 65. Novasign Business Overview Table 66. Novasign Bioprocess Platform Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Novasign Bioprocess Platform Software Product Portfolio Table 68. Novasign Recent Development Table 69. Qubicon Company Information Table 70. Qubicon Business Overview Table 71. Qubicon Bioprocess Platform Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Qubicon Bioprocess Platform Software Product Portfolio Table 73. Qubicon Recent Development Table 74. BioRaptor Company Information Table 75. BioRaptor Business Overview Table 76. BioRaptor Bioprocess Platform Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. BioRaptor Bioprocess Platform Software Product Portfolio Table 78. BioRaptor Recent Development Table 79. Merck Company Information Table 80. Merck Business Overview Table 81. Merck Bioprocess Platform Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Merck Bioprocess Platform Software Product Portfolio Table 83. Merck Recent Development Table 84. Bionet Company Information Table 85. Bionet Business Overview Table 86. Bionet Bioprocess Platform Software Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Bionet Bioprocess Platform Software Product Portfolio Table 88. Bionet Recent Development Table 89. Securecell Company Information Table 90. Securecell Business Overview Table 91. Securecell Bioprocess Platform Software Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Securecell Bioprocess Platform Software Product Portfolio Table 93. Securecell Recent Development Table 94. Vimachem Company Information Table 95. Vimachem Business Overview Table 96. Vimachem Bioprocess Platform Software Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Vimachem Bioprocess Platform Software Product Portfolio Table 98. Vimachem Recent Development Table 99. Scientific Industries Company Information Table 100. Scientific Industries Business Overview Table 101. Scientific Industries Bioprocess Platform Software Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Scientific Industries Bioprocess Platform Software Product Portfolio Table 103. Scientific Industries Recent Development Table 104. North America Bioprocess Platform Software Revenue by Type (2021-2026) & (US$ Million) Table 105. North America Bioprocess Platform Software Revenue by Type (2027-2032) & (US$ Million) Table 106. North America Bioprocess Platform Software Revenue by Application (2021-2026) & (US$ Million) Table 107. North America Bioprocess Platform Software Revenue by Application (2027-2032) & (US$ Million) Table 108. North America Bioprocess Platform Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. North America Bioprocess Platform Software Revenue by Country (2021-2026) & (US$ Million) Table 110. North America Bioprocess Platform Software Revenue by Country (US$ Million) & (2027-2032) Table 111. Europe Bioprocess Platform Software Revenue by Type (2021-2026) & (US$ Million) Table 112. Europe Bioprocess Platform Software Revenue by Type (2027-2032) & (US$ Million) Table 113. Europe Bioprocess Platform Software Revenue by Application (2021-2026) & (US$ Million) Table 114. Europe Bioprocess Platform Software Revenue by Application (2027-2032) & (US$ Million) Table 115. Europe Bioprocess Platform Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. Europe Bioprocess Platform Software Revenue by Country (2021-2026) & (US$ Million) Table 117. Europe Bioprocess Platform Software Revenue by Country (US$ Million) & (2027-2032) Table 118. China Bioprocess Platform Software Revenue by Type (2021-2026) & (US$ Million) Table 119. China Bioprocess Platform Software Revenue by Type (2027-2032) & (US$ Million) Table 120. China Bioprocess Platform Software Revenue by Application (2021-2026) & (US$ Million) Table 121. China Bioprocess Platform Software Revenue by Application (2027-2032) & (US$ Million) Table 122. Asia Bioprocess Platform Software Revenue by Type (2021-2026) & (US$ Million) Table 123. Asia Bioprocess Platform Software Revenue by Type (2027-2032) & (US$ Million) Table 124. Asia Bioprocess Platform Software Revenue by Application (2021-2026) & (US$ Million) Table 125. Asia Bioprocess Platform Software Revenue by Application (2027-2032) & (US$ Million) Table 126. Asia Bioprocess Platform Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Asia Bioprocess Platform Software Revenue by Region (US$ Million) & (2021-2026) Table 128. Asia Bioprocess Platform Software Revenue by Region (US$ Million) & (2027-2032) Table 129. SAMEA Bioprocess Platform Software Revenue by Type (2021-2026) & (US$ Million) Table 130. SAMEA Bioprocess Platform Software Revenue by Type (2027-2032) & (US$ Million) Table 131. SAMEA Bioprocess Platform Software Revenue by Application (2021-2026) & (US$ Million) Table 132. SAMEA Bioprocess Platform Software Revenue by Application (2027-2032) & (US$ Million) Table 133. SAMEA Bioprocess Platform Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. SAMEA Bioprocess Platform Software Revenue by Country (2021-2026) & (US$ Million) Table 135. SAMEA Bioprocess Platform Software Revenue by Country (US$ Million) & (2027-2032) Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Bioprocess Platform Software Image Figure 2. Global Bioprocess Platform Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bioprocess Platform Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cloud-based Image Figure 5. On-premise Image Figure 6. Global Bioprocess Platform Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Bioprocess Platform Software Market Size Share 2021 VS 2025 VS 2032 Figure 8. Upstream Processing (Cell Culture/Fermentation) Image Figure 9. Downstream Processing (Purification) Image Figure 10. Global Bioprocess Platform Software Market Size (US$ Million) & (2021-2032) Figure 11. Global Bioprocess Platform Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Bioprocess Platform Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Bioprocess Platform Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Bioprocess Platform Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Bioprocess Platform Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Bioprocess Platform Software Revenue Market Share by Type (2021-2032) Figure 18. Global Bioprocess Platform Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Bioprocess Platform Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Bioprocess Platform Software Revenue Market Share by Application (2021-2032) Figure 21. North America Bioprocess Platform Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Bioprocess Platform Software Revenue Share by Type (2021-2032) Figure 23. North America Bioprocess Platform Software Revenue Share by Application (2021-2032) Figure 24. North America Bioprocess Platform Software Revenue Share by Country (2021-2032) Figure 25. United States Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Bioprocess Platform Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Bioprocess Platform Software Revenue Share by Type (2021-2032) Figure 30. Europe Bioprocess Platform Software Revenue Share by Application (2021-2032) Figure 31. Europe Bioprocess Platform Software Revenue Share by Country (2021-2032) Figure 32. Germany Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Bioprocess Platform Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Bioprocess Platform Software Revenue Share by Type (2021-2032) Figure 42. China Bioprocess Platform Software Revenue Share by Application (2021-2032) Figure 43. Asia Bioprocess Platform Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Bioprocess Platform Software Revenue Share by Type (2021-2032) Figure 45. Asia Bioprocess Platform Software Revenue Share by Application (2021-2032) Figure 46. Asia Bioprocess Platform Software Revenue Share by Region (2021-2032) Figure 47. Japan Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Bioprocess Platform Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Bioprocess Platform Software Revenue Share by Type (2021-2032) Figure 55. SAMEA Bioprocess Platform Software Revenue Share by Application (2021-2032) Figure 56. SAMEA Bioprocess Platform Software Revenue Share by Country (2021-2032) Figure 57. Brazil Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Bioprocess Platform Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-premise
Applications
  • Upstream Processing (Cell Culture/Fermentation)
  • Downstream Processing (Purification)
Companies covered
  • Eppendorf
  • BioReact
  • Infors AG
  • Thermo Fisher Scientific
  • Invert
  • Genedata
  • Novasign
  • Qubicon
  • BioRaptor
  • Merck
  • Bionet
  • Securecell
  • Vimachem
  • Scientific Industries

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Bioprocess Platform Software Market by Type
  3. 1.2.1 Global Bioprocess Platform Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cloud-based
  5. 1.2.3 On-premise
  6. 1.3 Bioprocess Platform Software Market by Application
  7. 1.3.1 Global Bioprocess Platform Software Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Upstream Processing (Cell Culture/Fermentation)
  9. 1.3.3 Downstream Processing (Purification)
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Bioprocess Platform Software Market Dynamics
  1. 2.1 Bioprocess Platform Software Industry Trends
  2. 2.2 Bioprocess Platform Software Industry Drivers
  3. 2.3 Bioprocess Platform Software Industry Opportunities and Challenges
  4. 2.4 Bioprocess Platform Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Bioprocess Platform Software Market Perspective (2021-2032)
  2. 3.2 Global Bioprocess Platform Software Growth Trends by Region
  3. 3.2.1 Global Bioprocess Platform Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Bioprocess Platform Software Market Size by Region (2021-2026)
  5. 3.2.3 Global Bioprocess Platform Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Bioprocess Platform Software Revenue by Players
  2. 4.1.1 Global Bioprocess Platform Software Revenue by Players (2021-2026)
  3. 4.1.2 Global Bioprocess Platform Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Bioprocess Platform Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Bioprocess Platform Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Bioprocess Platform Software Key Players Headquarters & Area Served
  7. 4.4 Global Bioprocess Platform Software Players, Product Type & Application
  8. 4.5 Global Bioprocess Platform Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Bioprocess Platform Software Market CR5 and HHI
  11. 4.6.3 2025 Bioprocess Platform Software Tier 1, Tier 2, and Tier 3
5 Bioprocess Platform Software Market Size by Type
  1. 5.1 Global Bioprocess Platform Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Bioprocess Platform Software Revenue by Type (2021-2032)
  3. 5.3 Global Bioprocess Platform Software Revenue Market Share by Type (2021-2032)
6 Bioprocess Platform Software Market Size by Application
  1. 6.1 Global Bioprocess Platform Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Bioprocess Platform Software Revenue by Application (2021-2032)
  3. 6.3 Global Bioprocess Platform Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Eppendorf
  2. 7.1.1 Eppendorf Company Information
  3. 7.1.2 Eppendorf Business Overview
  4. 7.1.3 Eppendorf Bioprocess Platform Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Eppendorf Bioprocess Platform Software Product Portfolio
  6. 7.1.5 Eppendorf Recent Developments
  7. 7.2 BioReact
  8. 7.2.1 BioReact Company Information
  9. 7.2.2 BioReact Business Overview
  10. 7.2.3 BioReact Bioprocess Platform Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 BioReact Bioprocess Platform Software Product Portfolio
  12. 7.2.5 BioReact Recent Developments
  13. 7.3 Infors AG
  14. 7.3.1 Infors AG Company Information
  15. 7.3.2 Infors AG Business Overview
  16. 7.3.3 Infors AG Bioprocess Platform Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Infors AG Bioprocess Platform Software Product Portfolio
  18. 7.3.5 Infors AG Recent Developments
  19. 7.4 Thermo Fisher Scientific
  20. 7.4.1 Thermo Fisher Scientific Company Information
  21. 7.4.2 Thermo Fisher Scientific Business Overview
  22. 7.4.3 Thermo Fisher Scientific Bioprocess Platform Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Thermo Fisher Scientific Bioprocess Platform Software Product Portfolio
  24. 7.4.5 Thermo Fisher Scientific Recent Developments
  25. 7.5 Invert
  26. 7.5.1 Invert Company Information
  27. 7.5.2 Invert Business Overview
  28. 7.5.3 Invert Bioprocess Platform Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Invert Bioprocess Platform Software Product Portfolio
  30. 7.5.5 Invert Recent Developments
  31. 7.6 Genedata
  32. 7.6.1 Genedata Company Information
  33. 7.6.2 Genedata Business Overview
  34. 7.6.3 Genedata Bioprocess Platform Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Genedata Bioprocess Platform Software Product Portfolio
  36. 7.6.5 Genedata Recent Developments
  37. 7.7 Novasign
  38. 7.7.1 Novasign Company Information
  39. 7.7.2 Novasign Business Overview
  40. 7.7.3 Novasign Bioprocess Platform Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Novasign Bioprocess Platform Software Product Portfolio
  42. 7.7.5 Novasign Recent Developments
  43. 7.8 Qubicon
  44. 7.8.1 Qubicon Company Information
  45. 7.8.2 Qubicon Business Overview
  46. 7.8.3 Qubicon Bioprocess Platform Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Qubicon Bioprocess Platform Software Product Portfolio
  48. 7.8.5 Qubicon Recent Developments
  49. 7.9 BioRaptor
  50. 7.9.1 BioRaptor Company Information
  51. 7.9.2 BioRaptor Business Overview
  52. 7.9.3 BioRaptor Bioprocess Platform Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 BioRaptor Bioprocess Platform Software Product Portfolio
  54. 7.9.5 BioRaptor Recent Developments
  55. 7.10 Merck
  56. 7.10.1 Merck Company Information
  57. 7.10.2 Merck Business Overview
  58. 7.10.3 Merck Bioprocess Platform Software Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Merck Bioprocess Platform Software Product Portfolio
  60. 7.10.5 Merck Recent Developments
  61. 7.11 Bionet
  62. 7.11.1 Bionet Company Information
  63. 7.11.2 Bionet Business Overview
  64. 7.11.3 Bionet Bioprocess Platform Software Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Bionet Bioprocess Platform Software Product Portfolio
  66. 7.11.5 Bionet Recent Developments
  67. 7.12 Securecell
  68. 7.12.1 Securecell Company Information
  69. 7.12.2 Securecell Business Overview
  70. 7.12.3 Securecell Bioprocess Platform Software Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Securecell Bioprocess Platform Software Product Portfolio
  72. 7.12.5 Securecell Recent Developments
  73. 7.13 Vimachem
  74. 7.13.1 Vimachem Company Information
  75. 7.13.2 Vimachem Business Overview
  76. 7.13.3 Vimachem Bioprocess Platform Software Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Vimachem Bioprocess Platform Software Product Portfolio
  78. 7.13.5 Vimachem Recent Developments
  79. 7.14 Scientific Industries
  80. 7.14.1 Scientific Industries Company Information
  81. 7.14.2 Scientific Industries Business Overview
  82. 7.14.3 Scientific Industries Bioprocess Platform Software Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Scientific Industries Bioprocess Platform Software Product Portfolio
  84. 7.14.5 Scientific Industries Recent Developments
8 North America
  1. 8.1 North America Bioprocess Platform Software Revenue (2021-2032)
  2. 8.2 North America Bioprocess Platform Software Revenue by Type (2021-2032)
  3. 8.2.1 North America Bioprocess Platform Software Revenue by Type (2021-2026)
  4. 8.2.2 North America Bioprocess Platform Software Revenue by Type (2027-2032)
  5. 8.3 North America Bioprocess Platform Software Revenue Share by Type (2021-2032)
  6. 8.4 North America Bioprocess Platform Software Revenue by Application (2021-2032)
  7. 8.4.1 North America Bioprocess Platform Software Revenue by Application (2021-2026)
  8. 8.4.2 North America Bioprocess Platform Software Revenue by Application (2027-2032)
  9. 8.5 North America Bioprocess Platform Software Revenue Share by Application (2021-2032)
  10. 8.6 North America Bioprocess Platform Software Revenue by Country
  11. 8.6.1 North America Bioprocess Platform Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Bioprocess Platform Software Revenue by Country (2021-2026)
  13. 8.6.3 North America Bioprocess Platform Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Bioprocess Platform Software Revenue (2021-2032)
  2. 9.2 Europe Bioprocess Platform Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe Bioprocess Platform Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe Bioprocess Platform Software Revenue by Type (2027-2032)
  5. 9.3 Europe Bioprocess Platform Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe Bioprocess Platform Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe Bioprocess Platform Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe Bioprocess Platform Software Revenue by Application (2027-2032)
  9. 9.5 Europe Bioprocess Platform Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe Bioprocess Platform Software Revenue by Country
  11. 9.6.1 Europe Bioprocess Platform Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Bioprocess Platform Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe Bioprocess Platform Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Bioprocess Platform Software Revenue (2021-2032)
  2. 10.2 China Bioprocess Platform Software Revenue by Type (2021-2032)
  3. 10.2.1 China Bioprocess Platform Software Revenue by Type (2021-2026)
  4. 10.2.2 China Bioprocess Platform Software Revenue by Type (2027-2032)
  5. 10.3 China Bioprocess Platform Software Revenue Share by Type (2021-2032)
  6. 10.4 China Bioprocess Platform Software Revenue by Application (2021-2032)
  7. 10.4.1 China Bioprocess Platform Software Revenue by Application (2021-2026)
  8. 10.4.2 China Bioprocess Platform Software Revenue by Application (2027-2032)
  9. 10.5 China Bioprocess Platform Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Bioprocess Platform Software Revenue (2021-2032)
  2. 11.2 Asia Bioprocess Platform Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia Bioprocess Platform Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia Bioprocess Platform Software Revenue by Type (2027-2032)
  5. 11.3 Asia Bioprocess Platform Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia Bioprocess Platform Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia Bioprocess Platform Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia Bioprocess Platform Software Revenue by Application (2027-2032)
  9. 11.5 Asia Bioprocess Platform Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia Bioprocess Platform Software Revenue by Country
  11. 11.6.1 Asia Bioprocess Platform Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Bioprocess Platform Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia Bioprocess Platform Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Bioprocess Platform Software Revenue (2021-2032)
  2. 12.2 SAMEA Bioprocess Platform Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Bioprocess Platform Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Bioprocess Platform Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA Bioprocess Platform Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Bioprocess Platform Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Bioprocess Platform Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Bioprocess Platform Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA Bioprocess Platform Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Bioprocess Platform Software Revenue by Country
  11. 12.6.1 SAMEA Bioprocess Platform Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Bioprocess Platform Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Bioprocess Platform Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst